Manual Physical Therapy in the Treatment of Functional Constipation in Children: A Pilot Randomized Controlled Trial

María Blanco Díaz1, Carlos Bousoño García2, Diana Katherine Segura Ramírez2

  • 1Surgery and Medical Surgical Specialities Department, Faculty of Medicine and Health Sciences, University of Oviedo, Oviedo, Asturias, Spain.

Insights

Manual physical therapy (MPT) showed no significant difference compared to conventional pharmacologic treatment (CPT) for chronic pediatric functional constipation (CPC). However, MPT demonstrated advantages in improving children's quality of life.

Area of Science:

  • Pediatric Gastroenterology
  • Physical Therapy
  • Clinical Trials

Background:

  • Chronic pediatric functional constipation (CPC) affects children's quality of life and treatment efficacy.
  • Conventional pharmacologic treatment (CPT) is a common approach, but its long-term effectiveness and side effects are concerns.
  • Manual physical therapy (MPT) is an emerging therapeutic option for pediatric constipation.

Purpose of the Study:

  • To conduct a preliminary assessment of manual physical therapy (MPT) efficacy versus conventional pharmacologic treatment (CPT) in children with chronic pediatric functional constipation (CPC).
  • To compare outcomes including symptom severity, quality of life, stool form, and defecation frequency between MPT and CPT groups.
  • To evaluate the long-term efficacy of both treatments up to five years post-intervention.

Main Methods:

  • A pilot randomized controlled trial involving 47 children (2-14 years) with CPC.
  • Participants were randomized to either CPT (control group) or MPT (intervention group).
  • MPT involved nine sessions over three months; outcomes were assessed at baseline, 1, 3 months, and 5 years using Symptom Severity Score (SSS), Pediatric Quality of Life Inventory Scale, Bristol Stool Form Scale (BSFS), and defecation frequency (DF).

Main Results:

  • No statistically significant differences were found between MPT and CPT for SSS, BSFS, and DF at any follow-up point.
  • Both groups showed significant improvements over time in SSS, BSFS, and DF.
  • The MPT group demonstrated significantly higher quality of life scores at 3 months and 5 years compared to the CPT group.

Conclusions:

  • Preliminary evidence suggests MPT is not significantly different from CPT in improving objective measures of CPC.
  • MPT may offer advantages in enhancing the quality of life for children suffering from chronic functional constipation.
  • Further large-scale efficacy and noninferiority trials are warranted to confirm these findings and compare MPT directly with CPT.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
590
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
516
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
465
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
574
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
894
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
648